|4Dec 14, 5:13 PM ET

Greenway Schond L. 4

4 · Avalo Therapeutics, Inc. · Filed Dec 14, 2021

Insider Transaction Report

Form 4
Period: 2021-12-10
Transactions
  • Purchase

    Common Stock

    2021-12-10$1.57/sh+2,231$3,5033,883 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT